The work was funded by Novartis.
Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion need
Article first published online: 9 APR 2012
© 2012 American Association of Blood Banks
Volume 52, Issue 10, pages 2131–2138, October 2012
How to Cite
Goldberg, S. L., Chen, E., Sasane, M., Paley, C., Guo, A. and Laouri, M. (2012), Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion need. Transfusion, 52: 2131–2138. doi: 10.1111/j.1537-2995.2012.03626.x
- Issue published online: 30 OCT 2012
- Article first published online: 9 APR 2012
- Received for publication July 6, 2011; revision received December 16, 2011, and accepted January 2, 2012.
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.